In animal models of sepsis, intestinal glucose can induce the decrease of intestinal glucose levels and blood sugar, and GIP promotes insulin secretion, reduces glucagon secretion, increases insulin secretion, weakens the systemic inflammatory response, and improves hemodynamics (Shah et al., 2017). The gene discussed is INS; the disease is Sepsis.